MICHELLE STARNES: Open Payments
NPI 1487052445 · HICKORY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,299 in 60 payments from 24 companies in 2025. Trend: 2023 $1,464 · 2024 $850 · 2025 $1,299
Food & beverage: $1,299
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $443 |
| Axsome Therapeutics, Inc. | 4 | $158 |
| PFIZER INC. | 4 | $91 |
| AstraZeneca Pharmaceuticals LP | 4 | $91 |
| Lilly USA, LLC | 3 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
| Dexcom, Inc. | 2 | $43 |
| Boston Scientific Corporation | 1 | $37 |
| Amgen Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
Products named: QULIPTA, Auvelity, FARXIGA, UBRELVY, NURTEC ODT, VRAYLAR, XIFAXAN, Dexcom G6 Transmitter.
Industry payments across NC — which companies pay providers there.
